Cancer stem cell-like population is preferentially suppressed by EGFR-TKIs in EGFR-mutated PC-9 tumor models-Reference-Cited by-同舟云学术

Cancer stem cell-like population is preferentially suppressed by EGFR-TKIs in EGFR-mutated PC-9 tumor models

Published:2018-01 Issue:1 Volume:362 Page:195-202
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Yang Fan,Li Yang,Liu Bin,You Jiacong,Zhou Qinghua

Funder

National Natural Science Foundation of China

Key Project of International Cooperation of Science and Technology Innovation between Governments, the National Key Research and Development Plan of China

Publisher

Elsevier BV

Subject

Cell Biology

Reference42 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

3. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways;Sordella;Science,2004

4. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol.,2011

5. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP36 promotes tumor growth of non-small cell lung cancer via increasing KHK-A expression by regulating c-MYC–hnRNPH1/H2 axis;Human Cell;2022-02-08

2. Antimicrobial peptides: a promising strategy for lung cancer drug discovery?;Expert Opinion on Drug Discovery;2020-08-04

3. EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells;Advances in Cancer Research;2020

4. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells;Experimental Cell Research;2019-10